Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease

Fig. 2

Risk of pneumotoxicity with commonly prescribed rheumatological drugs according to rheumatologists and pulmonologists. A = Disease modifying anti-rheumatic drugs, B = Anti-TNF, C = Anti-IL1, D = Anti-IL6, E = T-Cell modulator, F = Anti-IL12/23, G = B-Cell modulator, H = Anti-IL17, I = JAKSTAT inihibitors. P values calculated for those reaching the 30% threshold (dotted line): * < 0.05 ** < 0.01, *** < 0.001

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us